CXCL1 and breast neoplasm: Expression of S100A7 in breast tumors negatively impacts prognosis through enhancing proliferation, production of proinflammatory molecules (IL-1α, CXC-L1, CXC-L8) (56) and tumor-associated macrophages (TAMs) recruitment (49, 56).